Cytarabine

We are Cytarabine CAS:147-94-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Cytarabine
CAS.NO:147-94-4
Synonyms:Cytosine β-D-Arabinofuranoside 
4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
Cytarabine
Arabinosylcytosine
4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
Ara-C
Molecular Formula:C9H13N3O5
Molecular Weight:243.21700
 
Physical and Chemical Properties:
Density:1.89
Melting point:214ºC
Boiling point:545.7ºC
Flash point:283.8ºC
Index of Refraction:1.756
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
Loss on drying:≤1.0%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Cytarabine is used as an antineoplastic and antiviral. It is a selective inhibitor of DNA synthesis. Does not inhibit RNA synthesis.
 
Cytarabine, or cytosine arabinoside, is a chemotherapy agent used mainly in the treatment of cancers of white blood cells such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma. It is also known as Ara-C (Arabinofuranosyl Cytidine). It destroys cancer cells by interfering with DNA synthesis.
 

Cytarabine


Related News: “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.51173-05-8 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.4-[(5-bromo-4,6-dichloropyrimidin-2-yl)amino]benzonitrile CAS:269055-75-6 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.98760-08-8 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity.

Related Products
Product Name
2,3-dibromoquinoxaline View Details
2-Chloro-3-fluoropyridine View Details
2-Cyano-3-(3-chlorophenylethyl)pyridine View Details
2-bromo-1-(3,5-difluorophenyl)ethanone manufacturer N,N’-(4,6-Dichloropyrimidine-2,5-diyl)diformamide manufacturer Vapreotide acetate manufacturer 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one manufacturer L-Threonine manufacturer